Applicability of Western protocols in resource-limited setting: Real-world data of long-term outcome of intensive treatment of adult acute myeloid leukaemia in Sri Lanka.
AML
Sri Lanka
developing countries
survival
Journal
EJHaem
ISSN: 2688-6146
Titre abrégé: EJHaem
Pays: United States
ID NLM: 101761942
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
received:
05
02
2021
revised:
10
03
2021
accepted:
12
03
2021
entrez:
18
7
2022
pubmed:
13
5
2021
medline:
13
5
2021
Statut:
epublish
Résumé
There are no published data on long-term survival and applicability of treatment protocols from developed countries in acute myeloid leukaemia (AML) in Sri Lanka. Eighty-seven AML patients were reviewed; there were 56 newly diagnosed patients between 18 and 65 years. Thirty-one out of 33 who started treatment achieved complete remission after first cycle of treatment. The induction mortality was one of 33. Twelve out of 20 patients who completed treatment are alive at the time of analysis. The estimated 5-year overall survival rate is 0.629. Strict infection control and treatment and superior clinical experience may have contributed towards better outcome.
Identifiants
pubmed: 35844682
doi: 10.1002/jha2.191
pii: JHA2191
pmc: PMC9176152
doi:
Types de publication
Case Reports
Langues
eng
Pagination
555-561Informations de copyright
© 2021 The Authors. eJHaem published by British Society for Haematology and John Wiley & Sons Ltd.
Déclaration de conflit d'intérêts
The authors declare that there is no conflict of interest.
Références
EClinicalMedicine. 2021 Jul 06;38:100998
pubmed: 34278283
Expert Rev Hematol. 2019 Aug;12(8):641-650
pubmed: 31159602
Indian J Hematol Blood Transfus. 2019 Apr;35(2):248-254
pubmed: 30988559
J Clin Oncol. 2017 Oct 20;35(30):3417-3424
pubmed: 28783450
Asia Pac J Clin Oncol. 2015 Sep;11(3):242-52
pubmed: 25639656
Blood. 2010 Jul 8;116(1):122-8
pubmed: 20395416
Br J Haematol. 2015 Jul;170(1):110-7
pubmed: 25858293
Br J Haematol. 2002 Aug;118(2):432-3
pubmed: 12139727
Curr Oncol Rep. 2020 Oct 6;22(12):125
pubmed: 33025161
Br J Haematol. 2017 Jun;177(6):846-854
pubmed: 28295193
Curr Hematol Malig Rep. 2019 Jun;14(3):171-178
pubmed: 31079354
JCO Glob Oncol. 2020 Nov;6:1684-1695
pubmed: 33156719
Leuk Res. 2013 Mar;37(3):245-50
pubmed: 23069745
Cancer Treat Rev. 2004 May;30(3):237-47
pubmed: 15059647
J Crit Care. 2015 Feb;30(1):111-5
pubmed: 25179411
J Clin Oncol. 2013 Sep 20;31(27):3360-8
pubmed: 23940227